Table 1.
Time taken from ethical and research governance approval submission to final approval to collect data for each study/country (n = 17).
| Months | Action | InSup-Ca | PACE |
|---|---|---|---|
| <1 | The Netherlands | Finland The Netherlands |
|
| 1–3 | Denmarkb
Slovenia |
Hungary | Belgium Switzerland United Kingdom |
| 3–6 | Belgium Italy |
United Kingdom | Italy |
| 6–9 | Germany | ||
| >12 | United Kingdom The Netherlands |
No response from Poland.
a
Missing data Belgium (InSup-C).
b
Ethical approval was not required as not a trial of a medicinal product, but additional approval was gained to screen medical records from the Danish Health and Medicines Authority.